D E Bergsagel. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenocarcinoma/drug therapyAnimalsAntineoplastic Agents/administration & dosageBone Marrow/drug effectsBone Marrow CellsCell DivisionCyclophosphamide/administration & dosageCytarabine/administration & dosageFemaleFluorouracil/administration & dosageHumansLeukemia L1210/drug therapyLeukemia, Lymphoid/drug therapyLymphoma/drug therapyMelphalan/administration & dosageMercaptopurine/administration & dosageMethotrexate/administration & dosageMiceMultiple Myeloma/drug therapyNeoplasms/drug therapyNitrogen Mustard Compounds/administration & dosagePrednisone/administration & dosagePregnancyTime FactorsTrophoblastic Neoplasms/drug therapyVinblastine/administration & dosage
Substances: See more » Antineoplastic AgentsNitrogen Mustard CompoundsCytarabineVinblastineCyclophosphamideMercaptopurineMelphalanFluorouracilPrednisoneMethotrexate
Year: 1971 PMID: 4322068 PMCID: PMC1930832
Source DB: PubMed Journal: Can Med Assoc J ISSN: 0008-4409 Impact factor: 8.262